KRT20 and colonic neoplasm: MS4A1 encodes the B cell surface marker CD20, is a member of the MS4A gene family which has been identified as n potential biomarker for predicting immunotherapy sensitivity in patients with colon cancer (CC) and having potential applications in gene therapy to inhibit CC progression.69